228 related articles for article (PubMed ID: 19692349)
1. Ku70 regulates Bax-mediated pathogenesis in laminin-alpha2-deficient human muscle cells and mouse models of congenital muscular dystrophy.
Vishnudas VK; Miller JB
Hum Mol Genet; 2009 Dec; 18(23):4467-77. PubMed ID: 19692349
[TBL] [Abstract][Full Text] [Related]
2. Aberrant Caspase Activation in Laminin-α2-Deficient Human Myogenic Cells is Mediated by p53 and Sirtuin Activity.
Yoon S; Beermann ML; Yu B; Shao D; Bachschmid M; Miller JB
J Neuromuscul Dis; 2018; 5(1):59-73. PubMed ID: 29278895
[TBL] [Abstract][Full Text] [Related]
3. Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy.
Rooney JE; Knapp JR; Hodges BL; Wuebbles RD; Burkin DJ
Am J Pathol; 2012 Apr; 180(4):1593-602. PubMed ID: 22322301
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy.
Girgenrath M; Dominov JA; Kostek CA; Miller JB
J Clin Invest; 2004 Dec; 114(11):1635-9. PubMed ID: 15578095
[TBL] [Abstract][Full Text] [Related]
5. Triggering regeneration and tackling apoptosis: a combinatorial approach to treating congenital muscular dystrophy type 1 A.
Yamauchi J; Kumar A; Duarte L; Mehuron T; Girgenrath M
Hum Mol Genet; 2013 Nov; 22(21):4306-17. PubMed ID: 23773998
[TBL] [Abstract][Full Text] [Related]
6. The DNA-PK catalytic subunit regulates Bax-mediated excitotoxic cell death by Ku70 phosphorylation.
Liu J; Naegele JR; Lin SL
Brain Res; 2009 Nov; 1296():164-75. PubMed ID: 19664609
[TBL] [Abstract][Full Text] [Related]
7. Highly efficient in vivo delivery of PMO into regenerating myotubes and rescue in laminin-α2 chain-null congenital muscular dystrophy mice.
Aoki Y; Nagata T; Yokota T; Nakamura A; Wood MJ; Partridge T; Takeda S
Hum Mol Genet; 2013 Dec; 22(24):4914-28. PubMed ID: 23882132
[TBL] [Abstract][Full Text] [Related]
8. CD90-positive cells, an additional cell population, produce laminin alpha2 upon transplantation to dy(3k)/dy(3k) mice.
Fukada S; Yamamoto Y; Segawa M; Sakamoto K; Nakajima M; Sato M; Morikawa D; Uezumi A; Miyagoe-Suzuki Y; Takeda S; Tsujikawa K; Yamamoto H
Exp Cell Res; 2008 Jan; 314(1):193-203. PubMed ID: 17963748
[TBL] [Abstract][Full Text] [Related]
9. Peripheral nerve pathology, including aberrant Schwann cell differentiation, is ameliorated by doxycycline in a laminin-α2-deficient mouse model of congenital muscular dystrophy.
Homma S; Beermann ML; Miller JB
Hum Mol Genet; 2011 Jul; 20(13):2662-72. PubMed ID: 21505075
[TBL] [Abstract][Full Text] [Related]
10. Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy.
Girgenrath M; Beermann ML; Vishnudas VK; Homma S; Miller JB
Ann Neurol; 2009 Jan; 65(1):47-56. PubMed ID: 19086074
[TBL] [Abstract][Full Text] [Related]
11. Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle.
Cohn RD; Mayer U; Saher G; Herrmann R; van der Flier A; Sonnenberg A; Sorokin L; Voit T
J Neurol Sci; 1999 Mar; 163(2):140-52. PubMed ID: 10371075
[TBL] [Abstract][Full Text] [Related]
12. Immortalized myogenic cells from congenital muscular dystrophy type1A patients recapitulate aberrant caspase activation in pathogenesis: a new tool for MDC1A research.
Yoon S; Stadler G; Beermann ML; Schmidt EV; Windelborn JA; Schneiderat P; Wright WE; Miller JB
Skelet Muscle; 2013 Dec; 3(1):28. PubMed ID: 24314268
[TBL] [Abstract][Full Text] [Related]
13. Maspin increases Ku70 acetylation and Bax-mediated cell death in cancer cells.
Lee SJ; Jang H; Park C
Int J Mol Med; 2012 Feb; 29(2):225-30. PubMed ID: 22076034
[TBL] [Abstract][Full Text] [Related]
14. Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A.
Doe JA; Wuebbles RD; Allred ET; Rooney JE; Elorza M; Burkin DJ
J Cell Sci; 2011 Jul; 124(Pt 13):2287-97. PubMed ID: 21652631
[TBL] [Abstract][Full Text] [Related]
15. Exon Skipping Using Antisense Oligonucleotides for Laminin-Alpha2-Deficient Muscular Dystrophy.
Hara Y; Mizobe Y; Miyatake S; Takizawa H; Nagata T; Yokota T; Takeda S; Aoki Y
Methods Mol Biol; 2018; 1828():553-564. PubMed ID: 30171567
[TBL] [Abstract][Full Text] [Related]
16. Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy.
Nguyen Q; Lim KRQ; Yokota T
Appl Clin Genet; 2019; 12():113-130. PubMed ID: 31308722
[TBL] [Abstract][Full Text] [Related]
17. Natural disease history of the dy2J mouse model of laminin α2 (merosin)-deficient congenital muscular dystrophy.
Pasteuning-Vuhman S; Putker K; Tanganyika-de Winter CL; Boertje-van der Meulen JW; van Vliet L; Overzier M; Plomp JJ; Aartsma-Rus A; van Putten M
PLoS One; 2018; 13(5):e0197388. PubMed ID: 29763467
[TBL] [Abstract][Full Text] [Related]
18. Linker proteins restore basement membrane and correct
Reinhard JR; Lin S; McKee KK; Meinen S; Crosson SC; Sury M; Hobbs S; Maier G; Yurchenco PD; Rüegg MA
Sci Transl Med; 2017 Jun; 9(396):. PubMed ID: 28659438
[No Abstract] [Full Text] [Related]
19. Potent pro-inflammatory and pro-fibrotic molecules, osteopontin and galectin-3, are not major disease modulators of laminin α2 chain-deficient muscular dystrophy.
Gawlik KI; Holmberg J; Svensson M; Einerborg M; Oliveira BM; Deierborg T; Durbeej M
Sci Rep; 2017 Mar; 7():44059. PubMed ID: 28281577
[TBL] [Abstract][Full Text] [Related]
20. HDAC6 deacetylates Ku70 and regulates Ku70-Bax binding in neuroblastoma.
Subramanian C; Jarzembowski JA; Opipari AW; Castle VP; Kwok RP
Neoplasia; 2011 Aug; 13(8):726-34. PubMed ID: 21847364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
